Submit articles to AIPMED Journal:

Submit an article


A. C. Jemilohun1 and O. G. Adewoye2

  1. Department of Medicine, Ladoke Akintola University of Technology/Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso, Oyo State, Nigeria
  2. Department of Medicine, Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso, Oyo State, Nigeria


Autoimmune hepatitis (AIH) is a rare cause of chronic liver disease (CLD). It presents with varied clinical features from acute hepatitis to CLDs like chronic viral hepatitis and alcoholic liver disease, making it difficult to diagnose in the absence of a high index of suspicion and adequate laboratory support. Autoantibody-mediated hepatocyte injury is the major feature of AIH.

We present a 44 year old woman with recurrent jaundice, ascites, splenomegaly, coagulopathy, negative chronic viral hepatitis screening, elevated IgG and positive anti-smooth muscle antibody. The patient responded well to immunosuppressive therapy. This report brings to the fore the need for physicians to maintain a high index of suspicion and thoroughly evaluate all CLD cases of seemingly ‘unknown’ etiology for AIH in order to prevent progression to end-stageliver-disease, since the disease is highly amenable to immunosuppressive therapy.

Keywords: Autoimmune hepatitis, Autoimmune liver disease, Chronic liver disease, Nigeria


Autoimmune hepatitis (AIH) is a non-contagious chronic inflammatory disease that results from autoantibody-mediated hepatocyte injury. Autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis are together classified as autoimmune liver disease.1

AIH is classified into different types on the basis of the serum autoantibody profiles. The common denominator for all the types is the presence of hypergammaglobulinemia, precisely IgG.2 Type 1 AIH is defined by the presence of antinuclear antibody (ANA), anti-smooth muscle antibody (Anti-SMA), or both and constitutes 80% of AIH cases.2 It is also commonly associated with other autoimmune diseases like autoimmune thyroiditis, celiac disease and ulcerative colitis, with about 25% having cirrhosis at presentation.2

Type 2 AIH is characterized by the presence of antiliver kidney microsomal (Anti-LKM) 1 and/or anti-LKM 3 and/or anti-liver cytosol 1 (Anti-LC1) antibodies.2 It is commoner in children, acute severe presentation does occur, and progression to cirrhosis commonly follows.2


The diagnosis of AIH is usually suspected when ongoing hepatocellular inflammation cannot be explained on the basis of chronic viral infection, alcohol consumption, or exposure to hepatotoxic medications or chemicals.2 As such, it is often a diagnosis of exclusion.

The incidence, prevalence and characteristics of AIH vary in different geographical regions. On a general note, it has a mean incidence of 1-2 per 100,000 and a point prevalence of 11–17 per 100,000. 2 It is commoner in women (especially young women) than men with a ratio around 4:1 but it occurs in all age groups, races and geographical areas. 2–5 The exact prevalence of the disease is not known in Nigeria as most studies on CLD focused on viral hepatitis, alcoholic liver disease and hepatocellular carcinoma. Only one case report of AIH in Nigeria was found in our literature search.6 A case of a 9-year-old girl with co-occurring wild-type chronic hepatitis B and antinuclear antibody-positive autoimmune hepatitis was reported in Senegal, a West African country.7 We present a young woman with liver cirrhosis that resulted from autoimmune hepatitis. The rarity of the disease, as well as the scarcity of reported cases in Nigeria, necessitated this effort.


A 44-year-old woman with a 4-week history of jaundice was referred to our clinic for evaluation. She was initially being evaluated for obstructive jaundice by a Gastrointestinal Surgeon in our hospital before the referral.

She had a history of dark color urine and pruritus which was limited to the extremities for which she was given cholestyramine by the referring doctor. She no longer had pruritus at the time she presented at our clinic despite having stopped taking cholestyramine. There was abdominal pain but no fever or passage of pale stool. No history of vomiting, diarrhea, or abdominal swelling. No history of blood transfusion, intravenous drug abuse, surgery or multiple sexual partners. Her haemoglobin genotype is AA. She had a similar history of jaundice 7 months before her presentation to us which resolved after receiving unspecified treatment at another facility. She was not previously diagnosed with any chronic illness.

She is the fifth of five children in a polygamous family setting. She has five children. No family history of a similar illness.

On physical examination, she was cachectic, deeply jaundiced but not pale. She had bilateral pitting pedal edema. The liver span was 8cm by percussion. She had moderate ascites, the blood pressure was normal but there was tachycardia (pulse was 112 per minute). The remainder of the examination was normal.

Read More